Differential cellular recognition of antigens during acute Plasmodium falciparum and Plasmodium vivax malaria

Journal of Infectious Diseases

Volumn 203, Issue 8, 2011, Pages 1192-1199

  Salwati, Ervi ^a   Minigo, Gabriela ^b,c   Woodberry, Tonia ^b   Piera, Kim A ^b   De Silva, Harini D ^c,g   Kenangalem, Enny ^d   Tjitra, Emiliana ^a   Coppel, Ross L ^c   Price, Ric N ^b,e,f   Anstey, Nicholas M ^b,f   Plebanski, Magdalena ^c  

^a NATIONAL INSTITUTE OF HEALTH RESEARCH AND DEVELOPMENT   (Indonesia)

^b MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d Menzies NIHRD Collaborative Research Program and District Health Authority   (Indonesia)

^e CHURCHILL HOSPITAL   (United Kingdom)

^f ROYAL DARWIN HOSPITAL   (Australia)

^g BURNET INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; MEROZOITE SURFACE PROTEIN 5; PARASITE ANTIGEN; TUBERCULIN; UNCLASSIFIED DRUG;

ADULT; ANTIGEN RECOGNITION; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CONVALESCENCE; CYTOKINE RELEASE; EFFECTOR CELL; FEMALE; HUMAN; HUMAN CELL; INDONESIA; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MALARIA FALCIPARUM; MALE; MEMORY T LYMPHOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMODIUM VIVAX MALARIA; PRIORITY JOURNAL; T LYMPHOCYTE;

ADULT; ANTIGENS, PROTOZOAN; FEMALE; HUMANS; IMMUNITY, CELLULAR; MALARIA, FALCIPARUM; MALARIA, VIVAX; MALE; MEMBRANE PROTEINS; PAPUA NEW GUINEA; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; SPECIES SPECIFICITY;

EID: 79953320405     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jiq166     Document Type: Article

References (50)

1. Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 2005; 434:214-7. (Pubitemid 40388051)
2. Price RN, Douglas NM, Anstey NM. New developments in Plasmodium vivax malaria: Severe disease and the rise of chloroquine resistance. Curr Opin Infect Dis 2009; 22:430-5.
3. Price RN, Tjitra E, Guerra CA, Yeung S, White NJ, Anstey NM. Vivax malaria: Neglected and not benign. Am J Trop Med Hyg 2007; 77:79-87.
4. Hviid L, Theander TG, Abu-Zeid YA, et al. Loss of cellular immune reactivity during acute Plasmodium falciparum malaria. FEMS Microbiol Immunol 1991; 3:219-27.
5. Bodescot M, Silvie O, Siau A, et al. Transcription status of vaccine candidate genes of Plasmodium falciparum during the hepatic phase of its life cycle. Parasitol Res 2004; 92:449-52. (Pubitemid 38658337)
6. Polson HE, Conway DJ, Fandeur T, Mercereau-Puijalon O, Longacre S. Gene polymorphism of Plasmodium falciparum merozoite surface proteins 4 and 5. Mol Biochem Parasitol 2005; 142:110-5. (Pubitemid 40720134)
7. Wu T, Black CG, Wang L, Hibbs AR, Coppel RL. Lack of sequence diversity in the gene encoding merozoite surface protein 5 of Plasmodium falciparum. Mol Biochem Parasitol 1999; 103:243-50. (Pubitemid 29469776)
8. Black CG, Barnwell JW, Huber CS, Galinski MR, Coppel RL. The Plasmodium vivax homologues of merozoite surface proteins 4 and 5 from Plasmodium falciparum are expressed at different locations in the merozoite. Mol Biochem Parasitol 2002; 120:215-24. (Pubitemid 34233786)
9. Woodberry T, Minigo G, Piera KA, et al. Antibodies to Plasmodium falciparum and Plasmodium vivax merozoite surface protein 5 in Indonesia: Species-specific and cross-reactive responses. J Infect Dis 2008; 198:134-42. (Pubitemid 351920300)
10. Karyana M, Burdarm L, Yeung S, et al. Malaria morbidity in Papua Indonesia, an area with multidrug resistant Plasmodium vivax and Plasmodium falciparum. Malar J 2008; 7:148.
11. Ratcliff A, Siswantoro H, Kenangalem E, et al. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: An open-label randomised comparison. Lancet 2007; 369:757-65. (Pubitemid 46335820)
12. Randall LM, Kenangalem E, Lampah DA, et al. Age-related susceptibility to severe malaria associated with galectin-2 in highland Papuans. J Infect Dis 2010; 202:117-24.
13. Marshall VM, Tieqiao W, Coppel RL. Close linkage of three merozoite surface protein genes on chromosome 2 of Plasmodium falciparum. Mol Biochem Parasitol 1998; 94:13-25. (Pubitemid 28345145)
14. Flanagan KL, Plebanski M, Akinwunmi P, et al. Broadly distributed T cell reactivity, with no immunodominant loci, to the pre-erythrocytic antigen thrombospondin-related adhesive protein of Plasmodium falciparum in West Africans. Eur J Immunol 1999; 29:1943-54. (Pubitemid 29265550)
15. Hemmer CJ, Holst FG, Kern P, Chiwakata CB, Dietrich M, Reisinger EC. Stronger host response per parasitized erythrocyte in Plasmodium vivax or ovale than in Plasmodium falciparum malaria. Trop Med Int Health 2006; 11:817-23. (Pubitemid 43846441)
16. Yeo TW, Lampah DA, Tjitra E, et al. Greater endothelial activation, Weibel-Palade body release and host inflammatory response to Plasmodium vivax, compared with Plasmodium falciparum: A prospective study in Papua, Indonesia. J Infect Dis 2010; 202:109-12.
17. Egan A, Waterfall M, Pinder M, Holder A, Riley E. Characterization of human T- and B-cell epitopes in the C terminus of Plasmodium falciparum merozoite surface protein 1: Evidence for poor T-cell recognition of polypeptides with numerous disulfide bonds. Infect Immun 1997; 65:3024-31.
18. al-Yaman F, Genton B, Taraika J, Anders R, Alpers MP. Cellular immunity to merozoite surface protein 2 (FC27 and 3D7) in Papua New Guinean children. Temporal variation and relation to clinical and parasitological status. Parasite Immunol 1997; 19:207-14.
19. Braga EM, Carvalho LH, Fontes CJ, Krettli AU. Low cellular response in vitro among subjects with long-term exposure to malaria transmission in Brazilian endemic areas. Am J Trop Med Hyg 2002; 66:299-303. (Pubitemid 34756100)
20. Reece WH, Plebanski M, Akinwunmi P, et al. Naturally exposed populations differ in their T1 and T2 responses to the circumsporozoite protein of Plasmodium falciparum. Infect Immun 2002; 70:1468-74. (Pubitemid 34163425)
21. Riley EM, Morris-Jones S, Taylor-Robinson AW, Holder AA. Lymphoproliferative responses to a merozoite surface antigen of Plasmodium falciparum: Preliminary evidence for seasonal activation of CD8+/HLA-DQ- restricted suppressor cells. Clin Exp Immunol 1993; 94:64-7.
22. Beck HP, Felger I, Genton B, et al. Humoral and cell-mediated immunity to the Plasmodium falciparum ring-infected erythrocyte surface antigen in an adult population exposed to highly endemic malaria. Infect Immun 1995; 63:596-600.
23. Connelly M, King CL, Bucci K, et al. T-cell immunity to peptide epitopes of liver-stage antigen 1 in an area of Papua New Guinea in which malaria is holoendemic. Infect Immun 1997; 65:5082-7. (Pubitemid 27513553)
24. Worku S, Troye-Blomberg M, Christensson B, Björkman A, Fehniger T. Activation of T cells in the blood of patients with acute malaria: Proliferative activity as indicated by Ki-67 expression. Scand J Immunol 2001; 53:296-301. (Pubitemid 32193697)
25. Flanagan KL, Mwangi T, Plebanski M, et al. Ex vivo interferon-gamma immune response to thrombospondin-related adhesive protein in coastal Kenyans: Longevity and risk of Plasmodium falciparum infection. Am J Trop Med Hyg 2003; 68:421-30. (Pubitemid 38230642)
26. Pouniotis DS, Proudfoot O, Bogdanoska V, Apostolopoulos V, Fifis T, Plebanski M. Dendritic cells induce immunity and long-lasting protection against blood-stage malaria despite an in vitro parasite-induced maturation defect. Infect Immun 2004; 72:5331-9. (Pubitemid 39223421)
27. Makobongo MO, Riding G, Xu H, et al. The purine salvage enzyme hypoxanthine guanine xanthine phosphoribosyl transferase is a major target antigen for cell-mediated immunity to malaria. Proc Natl Acad Sci USA 2003; 100:2628-33. (Pubitemid 36297549)
28. Pombo DJ, Lawrence G, Hirunpetcharat C, et al. Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum. Lancet 2002; 360:610-7. (Pubitemid 35232195)
29. Lee EA, Palmer DR, Flanagan KL, et al. Induction of T helper type 1 and 2 responses to 19-kilodalton merozoite surface protein 1 in vaccinated healthy volunteers and adults naturally exposed to malaria. Infect Immun 2002; 70:1417-21. (Pubitemid 34163419)
30. Anstey NM, Russell B, Yeo TW, Price RN. The pathophysiology of vivax malaria. Trends Parasitol 2009; 25:220-7.
31. Hviid L, Theander TG, Abdulhadi NH, Abu-Zeid YA, Bayoumi RA, Jensen JB. Transient depletion of T cells with high LFA-1 expression from peripheral circulation during acute Plasmodium falciparum malaria. Eur J Immunol 1991; 21:1249-53.
32. Elhassan IM, Hviid L, Satti G, et al. Evidence of endothelial inflammation, T cell activation, and T cell reallocation in uncomplicated Plasmodium falciparum malaria. Am J Trop Med Hyg 1994; 51:372-9. (Pubitemid 24300832)
33. Hviid L, Kurtzhals JA, Goka BQ, Oliver-Commey JO, Nkrumah FK, Theander TG. Rapid reemergence of T cells into peripheral circulation following treatment of severe and uncomplicated Plasmodium falciparum malaria. Infect Immun 1997; 65:4090-3. (Pubitemid 27422063)
34. Winkler S, Willheim M, Baier K, et al. Reciprocal regulation of Th1- and Th2-cytokine-producing T cells during clearance of parasitemia in Plasmodium falciparum malaria. Infect Immun 1998; 66:6040-4. (Pubitemid 28531874)
35. Bejon P, Mwacharo J, Kai O, et al. The induction and persistence of T cell IFN-c responses after vaccination or natural exposure is suppressed by Plasmodium falciparum. J Immunol 2007; 179:4193-201.
36. Ho M, Webster HK, Green B, Looareesuwan S, Kongchareon S, White NJ. Defective production of and response to IL-2 in acute human falciparum malaria. J Immunol 1988; 141:2755-9. (Pubitemid 18263064)
37. Walsh DS, Looareesuwan S, Vaniganonta S, Viravan C, Webster HK. Cutaneous delayed-type hypersensitivity responsiveness in patients during and after Plasmodium falciparum and Plasmodium vivaxinfections. Clin Immunol Immunopathol 1995; 77:89-94.
38. Njie R, Bell AI, Jia H, et al. The effects of acute malaria on Epstein-Barr virus (EBV) load and EBV-specific T cell immunity in Gambian children. J Infect Dis 2009; 199:31-8.
39. Moormann AM, Chelimo K, Sumba PO, Tisch DJ, Rochford R, Kazura JW. Exposure to holoendemic malaria results in suppression of Epstein-Barr virus-specific T cell immunosurveillance in Kenyan children. J Infect Dis 2007; 195:799-808. (Pubitemid 46363924)
40. Minigo G, Woodberry T, Piera KA, et al. Parasite-dependent expansion of TNF receptor II-positive regulatory T cells with enhanced suppressive activity in adults with severe malaria. PLoS Pathog 2009; 5:e1000402.
41. Goonewardene R, Carter R, Gamage CP, et al. Human T cell proliferative responses to Plasmodium vivax antigens: Evidence of immunosuppression following prolonged exposure to endemic malaria. Eur J Immunol 1990; 20:1387-91. (Pubitemid 20206105)
42. Schlotmann T, Waase I, Jülch C, et al. CD4 αβ T lymphocytes express high levels of the T lymphocyte antigen CTLA-4 (CD152) in acute malaria. J Infect Dis 2000; 182:367-70. (Pubitemid 30497834)
43. Goncxalves RM, Salmazi KC, Santos BA, et al. CD4+ CD25+ Foxp3+ regulatory T cells, dendritic cells, and circulating cytokines in uncomplicated malaria: Do different parasite species elicit similar host responses? Infect Immun 2010; 78:4763-72.
44. Jangpatarapongsa K, Chootong P, Sattabongkot J, et al. Plasmodium vivax parasites alter the balance of myeloid and plasmacytoid dendritic cells and the induction of regulatory T cells. Eur J Immunol 2008; 38:2697-705.
45. Bueno LL, Morais CG, Araújo FF, et al. Plasmodium vivax: Induction of CD4+CD25+FoxP3+ regulatory T cells during infection are directly associated with level of circulating parasites. PLoS One 2010; 5:e9623.
46. Chougnet C, Deloron P, Savel J. Persistence of cellular and humoral response to synthetic peptides from defined Plasmodium falciparum antigens. Ann Trop Med Parasitol 1991; 85:357-63.
47. Flanagan KL, Lee EA, Gravenor MB, et al. Unique T cell effector functions elicited by Plasmodium falciparum epitopes in malaria-exposed Africans tested by three T cell assays. J Immunol 2001; 167:4729-37. (Pubitemid 32954355)
48. Kabilan L, Sharma VP, Kaur P, Ghosh SK, Yadav RS, Chauhan VS. Cellular and humoral immune responses to well-defined blood stage antigens (major merozoite surface antigen) of Plasmodium falciparum in adults from an Indian zone where malaria is endemic. Infect Immun 1994; 62:685-91. (Pubitemid 24033792)
49. Chougnet C, Lepers JP, Astagneau P, Rason MD, Savel J, Deloron P. Lymphoproliferative responses to synthetic peptides from merozoite ring-infected erythrocyte surface antigen and circumsporozoite protein: A longitudinal study during a falciparum malaria episode. Am J Trop Med Hyg 1991; 45:560-6.
50. de Oliveira-Ferreira J, Banic DM, Santos F, Ferreira-da-Cruz MF, Dubois P, Daniel-Ribeiro CT. Cellular and antibody responses to the Plasmodium falciparum heat shock protein Pf72/HSP70 during and after acute malaria in individuals from an endemic area of Brazil. Acta Trop 1999; 73:1-10.